In a groundbreaking study, scientists have successfully used genetically modified pig kidneys to provide “life-saving kidney function” in a human for seven days.
This achievement marks a significant step in addressing the global shortage of human kidney donors. It demonstrates the potential of using pig kidneys to cure end-stage kidney disease and proves their safety when used with standard medications to suppress the immune system. The researchers aim to seek FDA approval for a Phase I clinical trial in living humans, offering hope for a solution to the organ shortage crisis responsible for thousands of preventable deaths each year.
These pig kidneys functioned normally, producing urine and remaining viable throughout the seven-day study, providing essential insights into the safety and efficacy of pig-to-human kidney transplants.